Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Mayfair Gold Corp. January 29, 2026 John Feneck: Silver’s Next Price Target, Plus 10 Stocks to Watch January 29, 2026 Chen Lin: Silver Price Breakout — Key Drivers, Next Catalyst January 29, 2026